Some selected abstract:

1

Bai N, Lai CS, He K, Zhou Z, Zhang L, Quan Z, Zhu N, Zheng QY, Pan MH, Ho CT.  Sesquiterpene lactones from Inula britannica and their cytotoxic and apoptotic effects on human cancer cell lines. J Nat Prod. 2006 Apr;69(4):531-5.

Department of Food Science, Rutgers University, 65 Dudley Road, New Brunswick, NJ 08901, USA.

Three new sesquiterpenes (1-3), together with four known sesquiterpene lactones, were isolated from the flowers of Inula britannica var. chinensis. Structures were established on the basis of high-field 1D and 2D NMR methods supported by HRMS. All sesquiterpene lactones were tested for cytotoxicity as well as apoptotic ratio in human COLO 205, HT 29, HL-60, and AGS cancer cells. Compounds 3 and 4, two alpha-methylene gamma-lactone-bearing sesquiterpenes, were modestly active in these assays.
 

Chang TT, Huang CC, Hsu CH. Clinical evaluation of the Chinese herbal medicine formula STA-1 in the treatment of allergic asthma. Phytother Res. 2006 May;20(5):342-7.

Graduate Institute of Chinese Medical Science, China Medical University, Taichung, Taiwan.

Although some formulae of traditional Chinese medicines (TCM) have been used for antiasthma treatment, few of them have had sufficient discussion on their efficacy, safety and mechanisms. In this study, the availability of the TCM formula STA-1 for the treatment of allergic asthma was investigated by conducting a double-blind, placebo-controlled and randomized trial. One hundred and twenty patients between the ages of 5 to 20 years with mild-to-moderate asthma were included. These patients were treated with either STA-1 or placebo in a dose of 80 g/kg/day and were administered twice daily for 6 months. The main outcome measures were a daily diary record of symptoms, supplementary bronchodilator and glucocorticoid treatment, changes of pulmonary function (forced expiratory volume in 1 s), changes of total and Dermatophagoides pteronyssinus (DP)-specific IgE and side effects. The results showed a statistically significant reduction of symptom scores, systemic steroid dose, total IgE and specific IgE in the STA-1 group. Furthermore, STA-1 also improved the pulmonary lung function FEV(1) compared with the placebo group and only minimal side effects were shown. These results suggested that STA-1 is available for the treatment of mild-to-moderate chronic asthma. Copyright 2006 John Wiley & Sons, Ltd.
 

Hargrave DR, Hargrave UA, Bouffet E. Quality of health information on the Internet in pediatric neuro-oncology. Neuro-oncol. 2006 Apr;8(2):175-82.

Royal Marsden Hospital, Sutton, Surrey SM2 5PT, UK. darren.hargrave@rmh.nhs.uk

The Internet is now the single largest source of health information and is used by many patients and their families who are affected by childhood brain tumors. To assess the quality of pediatric neuro-oncology information on the Internet, we used search engines to look for information on five common tumor types (brain stem glioma, craniopharyngioma, ependymoma, low-grade glioma, and medulloblastoma). The Web sites were evaluated for content quality by using the validated DISCERN rating instrument. Breadth of content and its accuracy were also scored by a checklist tool. Readability statistics were computed on the highest-rated sites. Of 114 evaluated Web sites, the sources were as follows: institutional, 46%; commercial, 35%; charitable, 15%; support group, 2%; and alternative medicine, 2%. Good interobserver correlation was found for both ratings instruments. The DISCERN tool rated Web sites as excellent (4%), good (7%), fair (29%), poor (39%), or very poor (21%). Only 5% of the Web sites provided one or more inaccurate pieces of information. Web sites were found deficient in topics covering etiology, late effects, prognosis, and treatment choices. Few sites offered information in languages other than English, and readability statistics showed an average required reading level of U.S. grade 12+ (the suggested level being grades 6-8 for an adult audience). The Internet is increasingly being used as a source of oncology information for patients and their families. Health care professionals should be actively involved in developing high-quality information for use in the next generation of Web sites.
 

Herman PM, D'Huyvetter K, Mohler MJ. Are health services research methods a match for CAM? Altern Ther Health Med. 2006 May-Jun;12(3):78-83. Review.

Program in Integrative Medicine, University of Arizona, Tucson, Arizona, USA.

BACKGROUND: Many complementary and alternative medicine (CAM) researchers believe that a new set of research methods is needed to study CAM. Health services research (HSR) is listed as a new research goal in the National Center for Complementary and Alternative Medicine 2005-2009 strategic plan. Does HSR offer solutions to the research needs of CAM? This article presents an overview of HSR, a summary of the HSR studies that have been published in CAM, and discussions of what HSR might offer CAM and what studies of CAM might offer conventional HSR. DISCUSSION: Our literature search, which was performed at the University of Arizona, found 84 published CAM HSR studies. A comparison of the search results-mostly surveys of CAM users or providers and economic outcome studies-with the breadth of topics that may be studied using HSR, showed that research in this field has not reached its potential. More work, including studies of interactions between patient, provider, and the system as well as patient-centered outcomes studies, is needed. Several areas in which CAM could benefit from HSR were identified and discussed. These included studies supporting the integration of CAM and conventional medicine, insurance coverage for CAM therapies, the development practice guidelines, and studies of the effectiveness and cost-effectiveness of CAM therapies and whole medical systems. The study of CAM, especially studies focusing on patients' attraction to CAM, may also help expand the topics and methods of conventional HSR. SUMMARY: HSR methods may address many of CAM's methodological challenges and improve clinical, patient-centered, and economic outcomes across all systems of care-both conventional and CAM.
 

Lian Z, Niwa K, Onogi K, Mori H, Harrigan RC, Tamaya T. Anti-tumor effects of herbal medicines on endometrial carcinomas via estrogen receptor-alpha-related mechanism. Oncol Rep. 2006 May;15(5):1133-6.

Department of Obstetrics and Gynecology, Gifu University School of Medicine, Yanagido, Gifu-city 501-1194, Japan.

This study was performed to examine the relationship between the anti-tumor effects of herbal medicine and endometrial carcinoma with ER-related mechanisms. An endometrial cancer cell line (Ishikawa) was used for this study. The cell viability and expression of estrogen receptors (ER) were determined by MTT and RT-PCR. A dose-dependent decrease of viability and apoptosis of the cancer cells was generated by exposure to the herbal medicines, Juzen-taiho-to or Shimotsu-to. The expression of ER-alpha mRNA, but not ER-beta mRNA was suppressed by Juzen-taiho-to or Shimotsu-to in an endometrial cancer cell line. The anti-tumor effect of these herbal medicines against endometrial carcinoma might be correlated to the ER-alpha related mechanism.
 

McAlister FA. The Canadian Hypertension Education Program--a unique Canadian initiative. Can J Cardiol. 2006 May 15;22(7):559-64.

Walter Mackenzie Centre, University of Alberta Hospital, 8440-112 Street, Edmonton, Alberta, Canada. finlay.mcalister@ualberta.ca

While almost two-thirds of all strokes and one-half of all myocardial infarctions could be prevented if hypertensive individuals had their blood pressures optimally controlled, only a minority of hypertensive individuals (even in publicly funded health care systems with subsidization of medication costs) achieve target blood pressures. Traditional hypertension guidelines have had limited impact on hypertension management and control rates. As a result, the Canadian Hypertension Education Program was developed to address the perceived flaws in the traditional hypertension guideline approach. In the present article, the key features of the Canadian Hypertension Education Program methodology are reviewed, with attention to those factors thought to be critical to the successful translation of recommendations into practice.
 

Passalacqua G, Bousquet PJ, Carlsen KH, Kemp J, Lockey RF, Niggemann B, Pawankar R, Price D, Bousquet J. ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol. 2006 May;117(5):1054-62.

Allergy and Respiratory Diseases, University of Genoa, Italy. passalacqua@unige.it

Complementary-alternative medicines are extensively used in the treatment of allergic rhinitis and asthma, but evidence-based recommendations are lacking. To provide evidence-based recommendations, the literature was searched by using MedLine and the Cochrane Library to March 2005 (Key words: Asthma [OR] Rhinitis, [AND] Complementary [OR] Alternative Medicine, [OR] Herbal, [OR] Acupuncture, [OR] Homeopathy, [OR] Alternative Treatment). Randomized trials, preferably double-blind and published in English, were selected. The articles were evaluated by a panel of experts. Quality of reporting was assessed by using the scale validated by Jadad. The methodology of clinical trials with complementary-alternative medicine was frequently inadequate. Meta-analyses provided no clear evidence for the efficacy of acupuncture in rhinitis and asthma. Some positive results were described with homeopathy in good-quality trials in rhinitis, but a number of negative studies were also found. Therefore it is not possible to provide evidence-based recommendations for homeopathy in the treatment of allergic rhinitis, and further trials are needed. A limited number of studies of herbal remedies showed some efficacy in rhinitis and asthma, but the studies were too few to make recommendations. There are also unresolved safety concerns. Therapeutic efficacy of complementary-alternative treatments for rhinitis and asthma is not supported by currently available evidence.
 

Sullivan R, Smith JE, Rowan NJ. Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine. Perspect Biol Med. 2006 Spring;49(2):159-70. Review.

Cancer Research UK, 61 Lincoln's Inn Field, London W2A 3PX, United Kingdom. richard.sullivan@cancer.org.uk

Modern medical practice relies heavily on the use of highly purified pharmaceutical compounds whose purity can be easily assessed and whose pharmaceutical activity and toxicity show clear structure-function relationships. In contrast, many herbal medicines contain mixtures of natural compounds that have not undergone detailed chemical analyses and whose mechanism of action is not known. Traditional folk medicine and ethno-pharmacology coupled to bioprospecting have been an important source of many anticancer agents as well as other medicines. With the current decline in the number of new molecular entities from the pharmaceutical industry, novel anticancer agents are being sought from traditional medicine. As the example of medicinal mushrooms demonstrates, however, translating traditional Eastern practices into acceptable evidence-based Western therapies is difficult. Different manufacturing standards, criteria of purity, and under-powered clinical trials make assessment of efficacy and toxicity by Western standards of clinical evidence difficult. Purified bioactive compounds derived from medicinal mushrooms are a potentially important new source of anticancer agents; their assimilation into Western drug discovery programs and clinical trials also provides a framework for the study and use of other traditional medicines.
 

Westergaard LG, Mao Q, Krogslund M, Sandrini S, Lenz S, Grinsted J. Acupuncture on the day of embryo transfer significantly improves the reproductive outcome in infertile women: a prospective, randomized trial. Fertil Steril. 2006 May;85(5):1341-6.

Fertility Clinic Trianglen, Hellerup, Denmark. l.g.westergaard@dadlnet.dk

OBJECTIVE: To evaluate the effect of acupuncture on reproductive outcome in patients treated with IVF/intracytoplasmic sperm injection (ICSI). One group of patients received acupuncture on the day of ET, another group on ET day and again 2 days later (i.e., closer to implantation day), and both groups were compared with a control group that did not receive acupuncture. DESIGN: Prospective, randomized trial. SETTING: Private fertility center. PATIENT(S): During the study period all patients receiving IVF or ICSI treatment were offered participation in the study. On the day of oocyte retrieval, patients were randomly allocated (with sealed envelopes) to receive acupuncture on the day of ET (ACU 1 group, n = 95), on that day and again 2 days later (ACU 2 group, n = 91), or no acupuncture (control group, n = 87). INTERVENTION(S): Acupuncture was performed immediately before and after ET (ACU 1 and 2 groups), with each session lasting 25 minutes; and one 25-minute session was performed 2 days later in the ACU 2 group. MAIN OUTCOME MEASURE(S): Clinical pregnancy and ongoing pregnancy rates in the three groups. RESULT(S): Clinical and ongoing pregnancy rates were significantly higher in the ACU 1 group as compared with controls (37 of 95 [39%] vs. 21 of 87 [26%] and 34 of 95 [36%] vs. 19 of 87 [22%]). The clinical and ongoing pregnancy rates in the ACU 2 group (36% and 26%) were higher than in controls, but the difference did not reach statistical difference. CONCLUSION(S): Acupuncture on the day of ET significantly improves the reproductive outcome of IVF/ICSI, compared with no acupuncture. Repeating acupuncture on ET day +2 provided no additional beneficial effect.
 

Zhang J, Wu TX, Liu GJ. Chinese herbal medicine for the treatment of pre-eclampsia. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD005126. Review.

BACKGROUND: Pre-eclampsia is a common disorder of pregnancy with uncertain etiology. In Chinese herbal medicines, a number of herbs are used for treating pre-eclampsia. Traditional Chinese medicine considers that, when a woman is pregnant, most of the blood of the mother is directed to the placenta to provide the baby with the required nutrition; other maternal organs may in consequence be vulnerable to damage. These organs include the liver, the spleen, and the kidneys. The general effects of Chinese herbal medicines that can protect these organs may be valuable in pre-eclampsia by encouraging vasodilatation, increasing blood flow, and decreasing platelet aggregation. The use of Chinese herbal medicine is often based on the individual and presence of traditional Chinese medicine symptoms. OBJECTIVES: To assess the effect of Chinese herbal medicine for treating pre-eclampsia and compare it with that of placebo, no treatment or Western medicine. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Groups Trial Register (31 March 2024), the Cochrane Central Register of Controlled Trials (The Cochrane Library, Issue 1, 2005), MEDLINE (1969 to December 2004), EMBASE (1984 to March 2004) and CBM (1978 to February 2005) and we handsearched several main journals published in China. SELECTION CRITERIA: Randomized controlled trials in which Chinese herbal medicine was used for treating pre-eclampsia. DATA COLLECTION AND ANALYSIS: One review author assessed trials for inclusion. The trials were also assessed by a second review author if there was any doubt about whether or not to include the trial. Analysis was not performed as there were no trials included in this review. MAIN RESULTS: No trials were suitable for inclusion in this review. AUTHORS' CONCLUSIONS: The effect of Chinese herbal medicine for treating pre-eclampsia remains unclear. There are currently no randomized controlled trials to address the efficacy and safety of Chinese herbal medicine for the treatment of pre-eclampsia. Well conducted randomized controlled trials are required.
 

 14917.     Alecrim-Andrade J, Maciel-Junior JA, Cladellas XC, Correa-Filho HR, Machado HC. Acupuncture in migraine prophylaxis: a randomized sham-controlled trial. Cephalalgia. 2006 May;26(5):520-9.

14918.     Aslan H, Zilberman Y, Arbeli V, Sheyn D, Matan Y, Liebergall M, Li JZ, Helm GA, Gazit D, Gazit Z. Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. Tissue Eng. 2006 Apr;12(4):877-89.

14919.     Balde NM, Youla A, Balde MD, Kake A, Diallo MM, Balde MA, Maugendre D. Herbal medicine and treatment of diabetes in Africa: an example from Guinea. Diabetes Metab. 2006 Apr;32(2):171-5. 

14920.     Bang MS, Lim SH. Paraplegia caused by spinal infection after acupuncture. Spinal Cord. 2006 Apr;44(4):258-9.

14921.     Barlas P, Ting SL, Chesterton LS, Jones PW, Sim J. Effects of intensity of electroacupuncture upon experimental pain in healthy human volunteers: a randomized, double-blind, placebo-controlled study. Pain. 2006 May;122(1-2):81-9.

14922.     Bartecchi CE. Complementary medicine has no place in cardiovascular medicine. J Am Coll Cardiol. 2006 Apr 4;47(7):1498-9; author reply 1499-500.

14923.     Bharathi K, Gopakumar K, Swamy RK. Evaluation of nidana and samprapti in the case of tamakasvasa (bronchial asthma). Aryavaidyan 2005 Aug-Oct; 19(1);47-50.

14924.     Black SL. To the point: acupuncture and migraine. Lancet Neurol. 2006 May;5(5):382-3; author reply 383.

14925.     Borysowski J, Weber-Dabrowska B, Gorski A. Bacteriophage endolysins as a novel class of antibacterial agents. Exp Biol Med (Maywood). 2006 Apr;231(4):366-77. Review.

14926.     Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006 May;10(4):287-333.

14927.     Chen JJ, Chou TH, Duh CY, Chen IS. Cytotoxic dihydroagarofuranoid sesquiterpenes from the stem of Microtropis fokienensis. J Nat Prod. 2006 Apr;69(4):685-8.

14928.     Cherigo L, Pereda-Miranda R. Resin glycosides from the flowers of Ipomoea murucoides. J Nat Prod. 2006 Apr;69(4):595-9.

14929.     Colvin L, Forbes K, Fallon M. Difficult pain. BMJ. 2006 May 6;332(7549):1081-3. Review.

14930.     Daniels AL, Van Slambrouck S, Lee RK, Arguello TS, Browning J, Pullin MJ, Kornienko A, Steelant WF. Effects of extracts from two Native American plants on proliferation of human breast and colon cancer cell lines in vitro. Oncol Rep. 2006 May;15(5):1327-31.

14931.     Dieterle S, Ying G, Hatzmann W, Neuer A. Effect of acupuncture on the outcome of in vitro fertilization and intracytoplasmic sperm injection: a randomized, prospective, controlled clinical study. Fertil Steril. 2006 May;85(5):1347-51.

14932.     Domar AD. Acupuncture and infertility: we need to stick to good science. Fertil Steril. 2006 May;85(5):1359-61; discussion 1368-70. Review.

14933.     Eleazer GP, Wieland D, Roberts E, Richeson N, Thornhill JT. Preparing medical students to care for older adults: the impact of a Senior Mentor Program. Acad Med. 2006 Apr;81(4):393-8.

14934.     Ezzo JM, Richardson MA, Vickers A, Allen C, Dibble SL, Issell BF, Lao L, Pearl M, Ramirez G, Roscoe J, Shen J, Shivnan JC, Streitberger K, Treish I, Zhang G. Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002285. Review. 

14935.     Fink M, Rosted P, Bernateck M, Stiesch-Scholz M, Karst M. Acupuncture in the treatment of painful dysfunction of the temporomandibular joint -- a review of the literature. Forsch Komplementarmed. 2006 Apr;13(2):109-15.

14936.     Folmer F, Blasius R, Morceau F, Tabudravu J, Dicato M, Jaspars M, Diederich M. Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives. Biochem Pharmacol. 2006 Apr 14;71(8):1206-18.

14937.     Fu ZH, Chen XY, Lu LJ, Lin J, Xu JG. Immediate effect of Fu's subcutaneous needling for low back pain. Chin Med J (Engl). 2006 Jun 5;119(11):953-6.

14938.     Gagnier JJ, van Tulder M, Berman B, Bombardier C. Herbal medicine for low back pain. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD004504. Review.

14939.     Gold PB, Glynn SM, Mueser KT. Challenges to implementing and sustaining comprehensive mental health service programs. Eval Health Prof. 2006 Jun;29(2):195-218.

14940.     Hall KB, Tett SE, Nissen LM. Perceptions of the influence of prescription medicine samples on prescribing by family physicians. Med Care. 2006 Apr;44(4):383-7.

14941.     Hargrave DR, Hargrave UA, Bouffet E. Quality of health information on the Internet in pediatric neuro-oncology. Neuro-oncol. 2006 Apr;8(2):175-82.

14942.     Huan SK, Lee HH, Liu DZ, Wu CC, Wang CC. Cantharidin-induced cytotoxicity and cyclooxygenase 2 expression in human bladder carcinoma cell line. Toxicology. 2006 Jun 1;223(1-2):136-43.

14943.     Hyman MA. The evolution of research: meeting the needs of systems medicine, part 1. Altern Ther Health Med. 2006 May-Jun;12(3):10-1. Review.

14944.     Irwin CE Jr. To test or not to test: screening for substance use in adolescents. J Adolesc Health. 2006 Apr;38(4):329-31.

14945.     Kaplan S. Yoga and the battlefield of ethics: highlighting an infusion model for ethics education. Sci Eng Ethics. 2006 Apr;12(2):391-8.

14946.     Keeling D, Davidson S, Watson H; Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. The management of heparin-induced thrombocytopenia. Br J Haematol. 2006 May;133(3):259-69.

14947.     Kim IJ, Kang JK, Lee SA. Factors contributing to the use of complementary and alternative medicine by people with epilepsy. Epilepsy Behav. 2006 May;8(3):620-4.

14948.     Kinney AJ. Metabolic engineering in plants for human health and nutrition. Curr Opin Biotechnol. 2006 Apr;17(2):130-8.

14949.     Kormosh N, Laktionov K, Antoshechkina M. Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer. Phytother Res. 2006 May;20(5):424-5.

14950.     Krivoy N, Habib M, Azzam ZS. Ethnic differences in population approach and experience regarding complementary-alternative medicine (CAM). Pharmacoepidemiol Drug Saf. 2006 May;15(5):348-53.

14951.     Lanzotti V. The analysis of onion and garlic. J Chromatogr A. 2006 Apr 21;1112(1-2):3-22.

14952.     Laurenson M. Working complementary therapies into mainstream health care. Br J Nurs. 2006 Apr 13-26;15(7):356-8.

14953.     Manosroi J, Dhumtanom P, Manosroi A. Anti-proliferative activity of essential oil extracted from Thai medicinal plants on KB and P388 cell lines. Cancer Lett. 2006 Apr 8;235(1):114-20.

14954.     Marian F, Widmer M, Herren S, Donges A, Busato A. Physicians' philosophy of care: a comparison of complementary and conventional medicine. Forsch Komplementarmed. 2006 Apr;13(2):70-7.

14955.     Maruyama M, Tomita N, Iwasaki K, Ootsuki M, Matsui T, Nemoto M, Okamura N, Higuchi M, Tsutsui M, Suzuki T, Seki T, Kaneta T, Furukawa K, Arai H. Benefits of combining donepezil plus traditional Japanese herbal medicine on cognition and brain perfusion in Alzheimer's disease: a 12-week observer-blind, donepezil monotherapy controlled trial. J Am Geriatr Soc. 2006 May;54(5):869-71.

14956.     Melnick SJ. Developmental therapeutics: review of biologically based complementary and alternative medicine (CAM) therapies for potential application in children with cancer-part II. J Pediatr Hematol Oncol. 2006 May;28(5):271-85. Review.

14957.     Melnick SJ. Developmental therapeutics: review of biologically based CAM therapies for potential application in children with cancer: part I. J Pediatr Hematol Oncol. 2006 Apr;28(4):221-30. Review.

14958.     Militao GC, Dantas IN, Pessoa C, Falcao MJ, Silveira ER, Lima MA, Curi R, Lima T, Moraes MO, Costa-Lotufo LV. Induction of apoptosis by pterocarpans from Platymiscium floribundum in HL-60 human leukemia cells. Life Sci. 2006 Apr 11;78(20):2409-17.

14959.     Moffet HH. Acupuncture for upper-extremity rehabilitation in chronic stroke. Arch Phys Med Rehabil. 2006 Apr;87(4):593-4; author reply 594-5.

14960.     Mruthyumjaya Rao M, Deep VC, Padhi MM, Das B, Nanda GC, Sahu DP. Application of leech therapy in the management of svitra (leukoderma). Aryavaidyan 2005 Feb-Apr; 19(3);144-147.

14961.     Murphy SP, Barr SI. Recommended Dietary Allowances should be used to set Daily Values for nutrition labeling. Am J Clin Nutr. 2006 May;83(5):1223S-1227S.

14962.     Norton SA. Whither medical botany? CMAJ. 2006 Jun 20;174(13):1877.

14963.     Panda AK, Tripathy PC, Nandy A. Clinical evaluation of swerta chirata in the treatment of P. vivax malaria. Aryavaidyan 2005 Aug-Oct; 19(1);39-42.

14964.     Passalacqua G, Bousquet PJ, Carlsen KH, Kemp J, Lockey RF, Niggemann B, Pawankar R, Price D, Bousquet J. ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol. 2006 May;117(5):1054-62.

14965.     Rankin-Box D. Shaping medical knowledge II: bias and balance. Complement Ther Clin Pract. 2006 May;12(2):77-9.

14966.     Raveendaran N, Ajjan N, Sekhar C, Rajesh SR. Factors influence contract farming of medicinal plant – the case of coleus (coleus forskohlii) – in Tamil Nadu. Aryavaidyan 2005 Aug-Oct; 19(1);32-38.

14967.     Reynolds D. Examining spirituality among women with breast cancer. Holist Nurs Pract. 2006 May-Jun;20(3):118-21. Review.

14968.     Robb WJ. Self-healing: a concept analysis. Nurs Forum. 2006 Apr-Jun;41(2):60-77. Review.

14969.     Robinson N. Integrated traditional Chinese medicine. Complement Ther Clin Pract. 2006 May;12(2):132-40.

14970.     Sall AA, Segeral O, Reynes JM, Lay S, Ouk V, Hak CR, Keo CL, Lefait RR, Delfraissy JF, Fontanet A.  Immunosuppression and GB virus C-RNA detection among HIV-infected patients in Cambodia. AIDS. 2006 May 12;20(8):1199-201.

14971.     Saunders B, Gower N. Prominent doctors and scientists reject Lancet report on homoeopathy. S Afr Med J. 2006 Apr;96(4):260, 262; discussion 262.

14972.     Schneider A, Enck P, Streitberger K, Weiland C, Bagheri S, Witte S, Friederich HC, Herzog W, Zipfel S. Acupuncture treatment in irritable bowel syndrome. Gut. 2006 May;55(5):649-54.

14973.     Simpson CA. Complementary medicine in chronic pain treatment. Phys Med Rehabil Clin N Am. 2006 May;17(2):451-72, viii. Review.

14974.     Smith C, Coyle M, Norman RJ. Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer. Fertil Steril. 2006 May;85(5):1352-8.

14975.     Srikanth N, Dua M, Bansal P, Misra DK. Role of eye exercise, topical and internal medication in myopia – a clinical study. Aryavaidyan 2005 Feb-Apr; 19(3);154-160.

14976.     Sumit K. A response to 'Evaluation of capsaicin ointment at the Korean hand acupressure point K-D2 for prevention of postoperative nausea and vomiting'. Anaesthesia. 2006 Jun;61(6):617; author reply 617.

14977.     Sung L, Feldman BM. N-of-1 trials: innovative methods to evaluate complementary and alternative medicines in pediatric cancer. J Pediatr Hematol Oncol. 2006 Apr;28(4):263-6.

14978.     Talokar SS, Deshmukh AA, Vadlamudi VP, Vasulkar RA, Shende NG. Study of haemato biochemical analysis of serum of helminth infested goats during the course of treatment with a composite herbal extract. Aryavaidyan 2005 Aug-Oct; 19(1);43-46.

14979.     Taylor AW, MacLennan AH, Avery JC. Postmenopausal hormone therapy: who now takes it and do they differ from non-users? Aust N Z J Obstet Gynaecol. 2006 Apr;46(2):128-35.

14980.     Tillisch K. Complementary and alternative medicine for functional gastrointestinal disorders. Gut. 2006 May;55(5):593-6.

14981.     Vas J, Perea-Milla E, Mendez C, Silva LC, Herrera Galante A, Aranda Regules JM, Martinez Barquin DM, Aguilar I, Faus V.  Efficacy and safety of acupuncture for the treatment of non-specific acute low back pain: a randomised controlled multicentre trial protocol [ISRCTN65814467].. BMC Complement Altern Med. 2006 Apr 21;6:14.

14982.     Vasulkar RA, Vadlamudi VP, Deshmukh AA. Anthelmintic evaluation of a composite herbal extract formulation. Aryavaidyan 2005 Aug-Oct; 19(1);58-60.

14983.     Vickery CE, Cotugna N. Complementary and alternative medicine education in dietetics programs: existent but not consistent. J Am Diet Assoc. 2006 Jun;106(6):860-6.

14984.     Wahlberg A. Bio-politics and the promotion of traditional herbal medicine in Vietnam. Health (London). 2006 Apr;10(2):123-47.

14985.     Wallace MB, Sullivan D, Rustgi AK; AITGN Symposium Faculty.  Advanced imaging and technology in gastrointestinal neoplasia: summary of the AGA-NCI Symposium October 4-5, 2004. Gastroenterology. 2006 Apr;130(4):1333-42.

14986.     Wan JM, Sit WH, Lee CL, Fu KH, Chan DK. Protection of lethal toxicity of endotoxin by Salvia miltiorrhiza BUNGE is via reduction in tumor necrosis factor alpha release and liver injury. Int Immunopharmacol. 2006 May;6(5):750-8.

14987.     Wang F, Hua H, Pei Y, Chen D, Jing Y. Triterpenoids from the resin of Styrax tonkinensis and their antiproliferative and differentiation effects in human leukemia HL-60 cells. J Nat Prod. 2006 May;69(5):807-10.

14988.     Wang KW, Mao JS, Tai YP, Pan YJ. Novel skeleton terpenes from Celastrus hypoleucus with anti-tumor activities. Bioorg Med Chem Lett. 2006 Apr 15;16(8):2274-7.

14989.     Westergaard LG, Mao Q, Krogslund M, Sandrini S, Lenz S, Grinsted J. Acupuncture on the day of embryo transfer significantly improves the reproductive outcome in infertile women: a prospective, randomized trial. Fertil Steril. 2006 May;85(5):1341-6.

14990.     Wilson KM, Klein JD, Sesselberg TS, Yussman SM, Markow DB, Green AE, West JC, Gray NJ. Use of complementary medicine and dietary supplements among U.S. adolescents. J Adolesc Health. 2006 Apr;38(4):385-94.

14991.     Winnick TA. Medical doctors and complementary and alternative medicine: the context of holistic practice. Health (London). 2006 Apr;10(2):149-73.

14992.     Wojcikowski K, Johnson DW, Gobe G. Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies. J Lab Clin Med. 2006 Apr;147(4):160-6. Review.

14993.     Xiao WL, Huang SX, Zhang L, Tian RR, Wu L, Li XL, Pu JX, Zheng YT, Lu Y, Li RT, Zheng QT, Sun HD. Nortriterpenoids from Schisandra lancifolia. J Nat Prod. 2006 Apr;69(4):650-3.

14994.     Xue CC, Li CG, Hugel HM, Story DF. Does acupuncture or Chinese herbal medicine have a role in the treatment of allergic rhinitis? Curr Opin Allergy Clin Immunol. 2006 Jun;6(3):175-9. Review.

14995.     Yadav PS, Sharma AK. Hypertension: An ayurvedic perspective. Aryavaidyan 2005 Nov – 2006 Jan; 19(2);86-92.

14996.     Yang H, Chen D, Cui QC, Yuan X, Dou QP. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res. 2006 May 1;66(9):4758-65.

14997.     Zaffani S, Cuzzolin L, Benoni G. Herbal products: behaviors and beliefs among Italian women. Pharmacoepidemiol Drug Saf. 2006 May;15(5):354-9.